Carsten Spannhuth

Chief Development Officer, CDO at NEUROLENTECH GmbH

Carsten Spannhuth, MD, eMBA is a highly experienced individual in the medical and biopharmaceutical field. Currently holding multiple key positions in various companies, Carsten is a driving force in the development of treatments for neurodegenerative, neurodevelopmental, and CNS disorders. With a strong background in clinical development and global leadership, Carsten has played pivotal roles in the success of numerous clinical development programs and licensing initiatives. Spannhuth's expertise spans across different therapeutic areas, showcasing their versatility and proficiency in the industry.

Links

Previous companies

Idorsia logo
Novartis logo
Sanofi logo
GeNeuro logo

Timeline

  • Chief Development Officer, CDO

    2024 - present